Vilzula D 10mg/100mg Tablet

Vilzula D 10mg 100mg Tablet is a potent combination antidiabetic medication containing of Dapagliflozin and Vildagliptin. It is used to manage type 2 diabetes mellitus in adults. By combining two different mechanisms, increasing glucose excretion through urine and enhancing the body's natural insulin production, it provides superior blood sugar control compared to either drug alone. This combination is particularly effective for patients whose blood sugar is not sufficiently controlled by metformin or single-agent therapies.

Vilzula D 10mg 100mg Tablet is an oral fixed-dose combination therapy designed for comprehensive glycemic management. It brings together two distinct classes of glucose-lowering agents: an SGLT2 inhibitor (Dapagliflozin) and a DPP-4 inhibitor (Vildagliptin).

Composition and Mechanism: Each tablet contains of Dapagliflozin and Vildagliptin. Dapagliflozin works in the kidneys by blocking the SGLT2 protein, which prevents glucose from being reabsorbed into the blood and instead flushes it out through urine. Vildagliptin works by inhibiting the DPP-4 enzyme, which slows the breakdown of incretin hormones. This signals the pancreas to produce more insulin when blood sugar is high and reduces the amount of sugar produced by the liver.

Major Therapeutic Uses: Vilzula D 10mg 100mg Tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is not for the treatment of type 1 diabetes or diabetic ketoacidosis. Beyond blood sugar, this combination is often favoured for patients who may benefit from the mild weight loss and blood pressure reduction associated with Dapagliflozin.

Benefits and Precautions: The dual-action formula targets the "triumvirate" of diabetes issues: insulin secretion, liver glucose production, and renal glucose reabsorption. A major benefit is the low risk of hypoglycemia (dangerously low blood sugar) when used without insulin or sulfonylureas. However, precautions must be taken regarding kidney function and the risk of genital fungal infections (thrush) or urinary tract infections due to the increased sugar in the urine.

Medical Supervision and Risks: Regular monitoring by a healthcare professional is mandatory. Key risks include dehydration, potential ketoacidosis (even if blood sugar levels are near normal), and pancreatitis (inflammation of the pancreas), which is a rare but serious risk associated with DPP-4 inhibitors. Patients with moderate to severe kidney impairment may not be suitable candidates for this specific strength.

Vilzula D 10mg 100mg Tablet (Dapagliflozin + Vildagliptin ) is indicated for:

Type 2 Diabetes Mellitus

Long-term management of blood glucose levels in adults.

HbA1c Reduction

Achieving and maintaining target haemoglobin A1c levels.

Combination Therapy

For patients needing multi-pathway treatment to reach glucose goals.

Cardiorenal Protection

Often used in patients where heart and kidney protection are secondary goals of therapy.

Vilzula D 10mg 100mg Tablet provides a synergistic approach to metabolic health. Its primary medicinal benefit is "glucose-dependent" control; it works hardest when your sugar is high but poses a lower risk of causing a "crash" when your sugar is normal. By removing excess sugar through the urine, Dapagliflozin helps lower the overall glucose load on the body, while Vildagliptin ensures the body utilises its own insulin more efficiently.

One of the significant advantages of this specific combination is its "weight-neutral to weight-positive" profile. While many diabetes medications cause weight gain, the Dapagliflozin component often leads to a modest loss of calories through glucose excretion, which can help offset the weight gain often seen in diabetic management. This makes it a preferred choice for patients struggling with obesity alongside diabetes.

Furthermore, Vilzula D 10mg 100mg Tablet offers cardiovascular and renal advantages. SGLT2 inhibitors like Dapagliflozin have been shown to reduce the risk of heart failure hospitalisation and slow the decline of kidney function. By combining this with the steady, reliable glycemic control of Vildagliptin, patients receive a holistic treatment that protects vital organs while maintaining day-to-day energy levels and reducing the long-term complications of diabetes, such as nerve damage or vision loss.

Common Side Effects (Generally manageable):

• Genital Yeast Infections: Due to increased sugar in the urine (thrush).

• Urinary Tract Infections (UTI): Increased frequency or burning during urination.

• Increased Urination: Needing to use the bathroom more frequently.

• Nasopharyngitis: Cold-like symptoms or a sore throat.

• Dizziness: Especially when first starting the medication.

Uncommon Side Effects:

• Constipation: Changes in bowel movements.

• Back Pain: Occasional musculoskeletal discomfort.

• Headache: Mild to moderate tension.

• Skin Rash: Itching or red spots.

Serious Side Effects (Requires immediate medical attention):

• Diabetic Ketoacidosis (DKA): Nausea, vomiting, abdominal pain, confusion, and fruity-smelling breath.

• Pancreatitis: Severe, persistent stomach pain that radiates to the back.

• Dehydration/Hypotension: Extreme thirst, very dry mouth, or fainting.

• Fournier’s Gangrene: Pain, swelling, or redness in the genital or anal area.

• Severe Allergic Reaction: Swelling of the face, tongue, or throat.

• Timing: Usually taken once daily in the morning.
• Method: Swallow the tablet whole with water. Do not crush, chew, or break it.
• With Food: Can be taken with or without food, but taking it after breakfast may reduce the risk of stomach upset.
• Consistency: Take it at the same time every day to maintain stable drug levels.
• Hydration: Drink plenty of water throughout the day to prevent dehydration and support the kidneys.

• The "Water" Rule: You will urinate more. Drink 8-10 glasses of water daily to stay hydrated.

• Hygiene is Key: To prevent yeast infections, keep the genital area clean and dry.

• Check Your Feet: Diabetes medications are not a substitute for daily foot checks; report any sores that won't heal.

• Sick Day Rules: If you have a severe illness, fever, or can't eat, talk to your doctor. You may need to pause the medication to avoid ketoacidosis.

Store Vilzula D 10mg 100mg Tablet at room temperature (below 30°C). Keep the tablets in their original moisture-resistant blister pack. Keep out of reach of children and pets.

• Alcohol: Increases the risk of a dangerous condition called lactic acidosis or ketoacidosis.

• Caffeine: May slightly increase the "jittery" feeling if your blood sugar is fluctuating.

Insulin / Sulfonylureas

MODERATE

It can cause hypoglycemia when combined. Doses of these drugs may need to be lowered.

Diuretics (Water Pills)

CAUTION

Increases the risk of severe dehydration and low blood pressure.

Corticosteroids

CAUTION

Steroids raise blood sugar and may make Vilzula D 10mg 100mg Tablet less effective.

ACE Inhibitors

MODERATE

May increase the blood-pressure-lowering effect of Dapagliflozin.

• Kidney Disease: If your kidney function (eGFR) drops below a certain level, this medicine may need to be stopped or the dose adjusted.

• Liver Disease: Vildagliptin requires healthy liver function; your doctor will perform liver enzyme tests before starting.

• Low Blood Pressure: Dapagliflozin can cause a drop in blood pressure; use with caution if you are prone to fainting.

Dosing must be guided by your HbA1c and kidney function.

• Standard Dose: One 10mg/100mg tablet taken once daily.

• Adjustment: Some doctors may start with a lower strength and titrate up to this 10mg/100mg dose.

• Max Dose: Generally one tablet per 24-hour period.

• Doctor's Direction: Do not change the dose or stop the medication without consulting your endocrinologist.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed one. Do not take two tablets at once to make up for a missed dose, as this increases the risk of dehydration and low blood sugar.